Biotech

Amedisys to Present at the 37th Annual J.P. Morgan Healthcare Conference Nasdaq:AMED

BATON ROUGE, La., Jan. 02, 2019 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED), one among America’s main residence health and hospice care corporations, right this moment introduced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 8, 2019.

The presentation will start at 11:30 a.m. Pacific Time.  To entry a reside webcast of the Amedisys presentation, please go browsing by our web site at http://investors.amedisys.com.

About Amedisys:

Amedisys, Inc. is a number one healthcare at residence Company delivering customized residence health, hospice and private care. Amedisys is concentrated on delivering the care that’s greatest for our sufferers, whether or not that’s home-based private care; restoration and rehabilitation after an operation or damage; care centered on empowering them to handle a continual illness; or hospice care at the finish of life. More than 3,000 hospitals and 59,000 physicians nationwide have chosen Amedisys as a companion in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an govt workplace in Nashville, TN, Amedisys is a publicly held firm. With greater than 19,000 workers in 422 care facilities in 34 states and the District of Columbia, Amedisys is devoted to delivering the highest high quality of care to the doorsteps of greater than 369,000 sufferers and purchasers in want yearly. For extra details about the Company, please go to: www.amedisys.com.

Contact:
Amedisys, Inc.
Investor Relations
855.259.2046
IR@amedisys.com

Source link

Tags
Show More

Related Articles

Back to top button
Close

Get Smallcap and Microcap News, Research, Trade Alerts & MORE, all 100% FREE!

Enter your email address to get started. All 100% Free.

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@smallcapsdaily.com